Cholesterol is recognized as a risk factor of aggressive prostate tumors, and dysfunctional ApoE2/E4 iso-form as a biomarker of aggressive disease [36] and ApoE containing HDL has been shown to overcome cholesterol-loaded adverse effects of HDL [37]. The gene discussed is APOE; the disease is prostate neoplasm.